The Epidemiology Consult Service at the United States Air Force School of Aerospace Medicine (USAFSAM)/Defense Centers for Public Health Dayton (DCPH-D) is assessing Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma (DIPG/DMG) occurrences at Cannon Air Force Base (AFB). This study is a result of concerns brought forth by service members and their families about an unusual occurrence of DIPG/DMG cases within the Cannon AFB population. This epidemiological study aims to identify DIPG/DMG cases over time and determine if the rates are higher at Cannon when compared to dependents within the rest of the Department of the Air Force (DAF) and the national average.
Air Force Special Operations Command leadership, in partnership with the USAFSAM/DCPH-D, the New Mexico Department of Health and the Brain Tumor Center at Cincinnati Children’s Hospital, continues to be engaged on this issue.
The Cannon Pediatric Brain Cancer Study has involved collecting and reviewing data regarding the cases of pediatric brain cancer from Cannon AFB, the surrounding regional area, other DAF locations, and the civilian population.
This website provides materials about DIPG/DMG to help educate and inform along with answers to frequently asked questions.
The safety and health of our Air Commandos and their families are our priority, and we are committed to understanding more about these vital concerns.
If you have questions or want to share information with us, please contact the Air Force Special Operations Command Public Affairs Office.